Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
Pre-Market: 20:00
Haemonetics Price : 108.40 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 108.02 | 109.49 | 107.38 | 108.40 | 641055.0 |
| Aug 21, 2026 | 109.24 | 109.57 | 107.00 | 108.80 | 582116.0 |
| Aug 20, 2026 | 106.84 | 109.56 | 106.49 | 108.22 | 891223.0 |
| Aug 19, 2026 | 105.20 | 108.50 | 105.01 | 108.41 | 1.460M |
| Aug 18, 2026 | 102.50 | 106.67 | 102.00 | 104.65 | 2.305M |
| Aug 17, 2026 | 90.09 | 91.36 | 89.06 | 90.27 | 469122.0 |
| Aug 14, 2026 | 90.61 | 91.49 | 89.82 | 90.80 | 533284.0 |
| Aug 13, 2026 | 91.63 | 92.25 | 89.91 | 90.38 | 811855.0 |
| Aug 12, 2026 | 86.38 | 91.39 | 86.14 | 91.34 | 822993.0 |
| Aug 11, 2026 | 86.79 | 88.88 | 86.10 | 87.22 | 745393.0 |
| Aug 10, 2026 | 87.39 | 87.97 | 85.97 | 86.61 | 571131.0 |
| Aug 07, 2026 | 85.55 | 87.87 | 84.88 | 87.84 | 657075.0 |
| Aug 06, 2026 | 85.77 | 88.00 | 80.83 | 85.02 | 1.275M |
| Aug 05, 2026 | 86.02 | 86.94 | 83.32 | 83.60 | 1.140M |
| Aug 04, 2026 | 86.06 | 87.08 | 85.32 | 85.38 | 1.273M |
| Aug 03, 2026 | 86.25 | 88.58 | 86.03 | 86.79 | 1.058M |
| Jul 31, 2026 | 84.26 | 85.61 | 82.75 | 85.54 | 789607.0 |
| Jul 30, 2026 | 84.58 | 84.97 | 83.48 | 84.82 | 555195.0 |
| Jul 29, 2026 | 81.99 | 85.71 | 81.72 | 85.42 | 893444.0 |
| Jul 28, 2026 | 81.14 | 83.24 | 80.37 | 82.54 | 803457.0 |
| Jul 27, 2026 | 79.35 | 80.72 | 79.35 | 79.91 | 803182.0 |
| Jul 24, 2026 | 78.32 | 79.41 | 77.27 | 78.78 | 462740.0 |
| Jul 23, 2026 | 77.65 | 78.34 | 74.95 | 77.40 | 598288.0 |
| Jul 22, 2026 | 78.17 | 78.38 | 76.22 | 78.03 | 363405.0 |
| Jul 21, 2026 | 77.41 | 78.15 | 76.94 | 78.07 | 371758.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Boston Scientific Corp. | 49.01 |
| Integra LifeSciences Holdings Corp. | 16.69 |
| Globus Medical, Inc. | 84.08 |
| Abbott Laboratories | 116.67 |
| AngioDynamics, Inc. | 15.77 |
Price Related Metrics
| PE Ratio | 52.87 |
| PS Ratio | 3.740 |
| Price to Book Value | 5.888 |
| Price to Free Cash Flow | 17.36 |
| Earnings Yield | 1.89% |
| Market Cap | 4.929B |
| Operating PE Ratio | 20.36 |
| Normalized PE Ratio | 32.44 |